Treatment of Respiratory Syncytial Virus Infections in Children

References

• Ruuskanen O, Ogra P L. Respiratory syncytial virus. Curr Probl Pediatr 1993; 23: 50–79
   PubMedGoogle Scholar
• Mäkelä M J, Mertsola J, Ruuskanen O. Respiratory syncytial virus infection in children. Curr Opin Pediatr 1994; 6: 17–22
   PubMedGoogle Scholar
• Navas L, Wang E, de Carvalho V, Robinson J, Pediatric Investigators Collaborative Network on Infections in Canada. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 1992; 121: 348–54
   PubMed Web of Science ®Google Scholar
• Law B J, de Carvalho V, Pediatric Investigators Collaborative Network on Infections in Canada. Respiratory syncytial virus infections in hospitalized Canadian children: regional differences in patient populations and management practises. Pediatr Infect Dis J 1993; 12: 659–63
   PubMedGoogle Scholar
• Goodman B T, Chambers T L. Bronchodilators for bronchiolitis?. Lancer 1993; 341: 1380
   PubMed Web of Science ®Google Scholar
• Gadomski A M, Aref G H, Ei Din O B, Ei Sawy I H, Khallaf N, Black R E. Oral versus nebulized albuterol in the management of bronchiolitis in Egypt. J Pediatr 1994; 124: 131–8
   PubMed Web of Science ®Google Scholar
• Hickey R W, Gochman R F, Chande V, Davis H W. Albuterol delivered via metered-dose inhaler with spacer for outpatient treatment in young children with wheezing. Arch Pediatr Adolesc Med 1994; 148: 189–94
   PubMedGoogle Scholar
• Henderson A JW, Yung S, Stick S M, Landau L I, LeSouef P N. Effect of salbutamol on histamine induced bronchoconstriction in healthy infants. Thorax 1993; 48: 317–23
   PubMedGoogle Scholar
• Sanchez I, De Koster J, Powell R E, Wolstein R, Chernick V. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 1993; 122: 145–51
   PubMed Web of Science ®Google Scholar
• Wheeler J G, Wofford J, Turner R B. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr Infect Dis J 1993; 12: 209–13
   PubMedGoogle Scholar
• Daugbjerg P, Brenøe E, Forchhammer H, et al. A comparison between nebulized turbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatr 1993; 82: 547–51
   PubMed Web of Science ®Google Scholar
• Hemming V G, Rodriguez W, Kim H W, et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 1987; 31: 1882–6
   PubMed Web of Science ®Google Scholar
• Piazza F M, Johnson S A, Ottolini M G, et al. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol. J Infect Dis 1992; 166: 1422–4
   PubMed Web of Science ®Google Scholar
• Crowe J E, Murphy B R, Chanock R M, et al. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci USA 1994; 91: 1386–90
   PubMedGoogle Scholar
• Groothuis J R, Simoes E AF, Levin M J, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993; 329: 1524–30
   PubMed Web of Science ®Google Scholar
• Gadomski A M. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J 1993; 12: 115–20
   PubMed Web of Science ®Google Scholar
• Tristram D A, Welliver R C, Hogerman D A, et al. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement. Vaccine 1994; 12: 551–6
   PubMedGoogle Scholar
• Madge P, Paton J Y, McColl J H, Mackie P LK. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992; 340: 1079–83
   PubMed Web of Science ®Google Scholar